Alveolar-interstitial pneumopathy after gold-salts compounds administration, requiring mechanical ventilation

Intensive Care Medicine

Volumn 24, Issue 10, 1998, Pages 1110-1112

  Blancas, R ^a   Moreno, J L ^a   Martin F ^a   De La Casa, R ^a   Onoro J J ^a   Gomez V ^a   Prados, J ^a  

^a Clinica Moncloa   (Spain)

Author keywords

Bronchiolitis obliterans; Bronchiolitis obliterans with organizing pneumonia; Gold lung; Gold salts compounds; Rheumatoid lung

Indexed keywords

AURANOFIN; AUROTHIOMALATE; GOLD SALT; METHYLPREDNISOLONE; STEROID;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL FEATURE; EXAMINATION; HUMAN; INTERSTITIAL LUNG DISEASE; INTRAMUSCULAR DRUG ADMINISTRATION; LUNG FUNCTION TEST; MALE; ORAL DRUG ADMINISTRATION; RADIOLOGICAL PROCEDURES; RESPIRATORY FAILURE; RHEUMATOID ARTHRITIS;

AGED; ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BRONCHIOLITIS OBLITERANS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; METHYLPREDNISOLONE; ORGANOGOLD COMPOUNDS; POSITIVE-PRESSURE RESPIRATION; PROGNOSIS;

EID: 0031792187     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050725     Document Type: Article

References (10)

1. Evans RB, Ettensohn DB, Fawaz-Estrup F, Lally EV, Kaplan SR (1987) Gold lung: recent developments in pathogenesis, diagnosis and therapy. Semin Arthritis Rheum 16: 196-205
2. Zitnik RJ, Cooper JA (1990) Pulmonary disease due to antirheumatic agents. Clin Chest Med 11: 139-50
3. Anaya JM, Diethelm L, Ortiz LA, Gutiérrez M, Citera G, Welsh RA, Espinoza LR (1995) Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 24: 242-254
4. Tomioka H, King TE (1997) Gold-induced, pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease. Am J Respir Crit Care Med 155: 1011-1020
5. Cooper JA, While DA, Matthay RA (1986) Drug-induced pulmonary disease. Part 2: noncytotoxic drugs. Am J Respir Crit Care Med 133: 488-505
6. Fort JG, Scovern H, Abruzzo JL (1988) Intravenous cyclophosphamide and methylprednisolone for the treatment of bronchiolitis obliterans and interstitial fibrosis associated with erysotherapy. J Rheum 15: 850-854
7. O'Duffy JD, Harvinder S, Luthra K, Krishnan U, Hyatt E (1986) Bronchiolitis in a rheumatoid arthritis patient receiving auranofin. Arthritis Rheum 29: 556-559
8. Holness L, Tenenbaum J, Cooter NB, Gorssman RF (1983) Fatal bronchiolitis obliterans associated with chrysotherapy. Ann Rheum Dis 42: 593-596
9. van Thiel RJ, van der Burg S, Groote AD, Nossent GD, Wills SH (1991) Bronchiolitis obliterans organizing pneumonia and rheumatoid arthritis. Eur Respir J 4: 905-911
10. Fernández Alvarez R, Domínguez del Alamo MJ, Molinos Martín L, Babío Herráez J (1994) Toxiciddad pulmonar asociada a tratamiento con sales de oro: experiencia con 4 casos. Med Clin (Barc) 102:475